サマリー

非侵襲的非経口的スクリーニングは、母親の血清中に存在する胎児の細胞遊離DNAを検査し、一般的な胎児の異数性を検出する新しい遺伝学的プロセスである。その主な目的は、トリソミー21（ダウン症候群）、トリソミー18（エドワード症候群）、トリソミー13（パタウ症候群）、モノソミーX（ターナー症候群）などの遺伝性疾患の早期発見です。また、胎児の血液型やアカゲザルを検出することもできます。現在、世界市場で販売されているNIPTの中には、MaterniT21 PLUS、Harmony、Panorama、NIFTY、PrenaTest、BambniTestなどの製品があります。

市場分析と洞察。世界および米国の非侵襲的非経口的スクリーニング機器市場
当レポートでは、世界および米国の非侵襲的非経口スクリーニング機器市場に焦点を当てています。
2020年の非侵襲性非経口スクリーニング機器の世界市場規模はXX百万米ドルで、2021年から2027年の間にXX％のCAGRで、2027年末にはXX百万米ドルに達すると予想されています。米国では、非侵襲的非経口スクリーニング機器の市場規模は、2020年のXX百万米ドルから2027年にはXX百万米ドルまで、予測期間中にXX％のCAGRで成長すると予測されています。

世界の非侵襲的非経口スクリーニング装置の範囲と市場規模
非侵襲的非経口スクリーニング機器市場は、地域（国）別、プレイヤー別、タイプ別、アプリケーション別に分類されます。世界の非侵襲的非経口的スクリーニング機器市場のプレーヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント別分析では、地域（国）別、タイプ別、アプリケーション別に、2016年から2027年までの収益と予測に焦点を当てています。
米国市場では、2016-2027年の非侵襲的非経口スクリーニング機器の市場規模を、プレイヤー別、タイプ別、アプリケーション別に分析しています。主要なプレイヤーには、アメリカ合衆国で重要な役割を果たす世界的なプレイヤーや地域のプレイヤーが含まれます。

タイプ別セグメント
超音波診断装置
次世代シークエンス装置
ポリメラーゼ連鎖反応装置
マイクロアレイ
その他

用途別セグメント
診断機関
病院

地域別
北アメリカ
U.S.
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
アジアパシフィック
中国
日本
韓国
インド
オーストラリア
台湾
インドネシア
タイ
マレーシア
フィリピン
ベトナム
ラテンアメリカ
メキシコ
ブラジル
アルゼンチン
中近東・アフリカ
トルコ
サウジアラビア
U.A.E.

会社別
GEヘルスケア
フィリップス
イルミナ
サーモフィッシャーサイエンティフィック
ロシュ
パックバイオ
パーキネルマー
チーゲン
アジレント・テクノロジー
BGIグループ

ページTOPに戻る

目次

1 Study Coverage
1.1 Non-invasive Parenteral Screening Instruments Product Introduction
1.2 Market by Type
1.2.1 Global Non-invasive Parenteral Screening Instruments Market Size Growth Rate by Type
1.2.2 Ultrasound Devices
1.2.3 Next-Generation Sequencing Systems
1.2.4 Polymerase Chain Reaction Instruments
1.2.5 Microarrays
1.2.6 Others
1.3 Market by Application
1.3.1 Global Non-invasive Parenteral Screening Instruments Market Size Growth Rate by Application
1.3.2 Diagnostic Laboratories
1.3.3 Hospitals
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Non-invasive Parenteral Screening Instruments Market Size, Estimates and Forecasts
2.1.1 Global Non-invasive Parenteral Screening Instruments Revenue 2016-2027
2.1.2 Global Non-invasive Parenteral Screening Instruments Sales 2016-2027
2.2 Global Non-invasive Parenteral Screening Instruments, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Non-invasive Parenteral Screening Instruments Historical Market Size by Region (2016-2021)
2.3.1 Global Non-invasive Parenteral Screening Instruments Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Non-invasive Parenteral Screening Instruments Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Non-invasive Parenteral Screening Instruments Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Non-invasive Parenteral Screening Instruments Sales Forecast by Region (2022-2027)
2.4.2 Global Non-invasive Parenteral Screening Instruments Revenue Forecast by Region (2022-2027)

3 Global Non-invasive Parenteral Screening Instruments Competitor Landscape by Players
3.1 Global Top Non-invasive Parenteral Screening Instruments Manufacturers by Sales
3.1.1 Global Non-invasive Parenteral Screening Instruments Sales by Manufacturer (2016-2021)
3.1.2 Global Non-invasive Parenteral Screening Instruments Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Non-invasive Parenteral Screening Instruments Manufacturers by Revenue
3.2.1 Key Non-invasive Parenteral Screening Instruments Manufacturers Covered: Ranking by Revenue
3.2.2 Global Non-invasive Parenteral Screening Instruments Revenue by Manufacturers (2016-2021)
3.2.3 Global Non-invasive Parenteral Screening Instruments Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Non-invasive Parenteral Screening Instruments Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Non-invasive Parenteral Screening Instruments Revenue in 2020
3.2.6 Global Non-invasive Parenteral Screening Instruments Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Non-invasive Parenteral Screening Instruments Price by Manufacturers
3.4 Global Non-invasive Parenteral Screening Instruments Manufacturing Base Distribution, Product Types
3.4.1 Non-invasive Parenteral Screening Instruments Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Non-invasive Parenteral Screening Instruments Product Type
3.4.3 Date of International Manufacturers Enter into Non-invasive Parenteral Screening Instruments Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Non-invasive Parenteral Screening Instruments Market Size by Type (2016-2021)
4.1.1 Global Non-invasive Parenteral Screening Instruments Sales by Type (2016-2021)
4.1.2 Global Non-invasive Parenteral Screening Instruments Revenue by Type (2016-2021)
4.1.3 Non-invasive Parenteral Screening Instruments Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Non-invasive Parenteral Screening Instruments Market Size Forecast by Type (2022-2027)
4.2.1 Global Non-invasive Parenteral Screening Instruments Sales Forecast by Type (2022-2027)
4.2.2 Global Non-invasive Parenteral Screening Instruments Revenue Forecast by Type (2022-2027)
4.2.3 Non-invasive Parenteral Screening Instruments Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Non-invasive Parenteral Screening Instruments Market Size by Application (2016-2021)
5.1.1 Global Non-invasive Parenteral Screening Instruments Sales by Application (2016-2021)
5.1.2 Global Non-invasive Parenteral Screening Instruments Revenue by Application (2016-2021)
5.1.3 Non-invasive Parenteral Screening Instruments Price by Application (2016-2021)
5.2 Non-invasive Parenteral Screening Instruments Market Size Forecast by Application (2022-2027)
5.2.1 Global Non-invasive Parenteral Screening Instruments Sales Forecast by Application (2022-2027)
5.2.2 Global Non-invasive Parenteral Screening Instruments Revenue Forecast by Application (2022-2027)
5.2.3 Global Non-invasive Parenteral Screening Instruments Price Forecast by Application (2022-2027)

6 United States by Players, Type and Application
6.1 United States Non-invasive Parenteral Screening Instruments Market Size YoY Growth 2016-2027
6.1.1 United States Non-invasive Parenteral Screening Instruments Sales YoY Growth 2016-2027
6.1.2 United States Non-invasive Parenteral Screening Instruments Revenue YoY Growth 2016-2027
6.1.3 United States Non-invasive Parenteral Screening Instruments Market Share in Global Market 2016-2027
6.2 United States Non-invasive Parenteral Screening Instruments Market Size by Players (International and Local Players)
6.2.1 United States Top Non-invasive Parenteral Screening Instruments Players by Sales (2016-2021)
6.2.2 United States Top Non-invasive Parenteral Screening Instruments Players by Revenue (2016-2021)
6.3 United States Non-invasive Parenteral Screening Instruments Historic Market Review by Type (2016-2021)
6.3.1 United States Non-invasive Parenteral Screening Instruments Sales Market Share by Type (2016-2021)
6.3.2 United States Non-invasive Parenteral Screening Instruments Revenue Market Share by Type (2016-2021)
6.3.3 United States Non-invasive Parenteral Screening Instruments Price by Type (2016-2021)
6.4 United States Non-invasive Parenteral Screening Instruments Market Estimates and Forecasts by Type (2022-2027)
6.4.1 United States Non-invasive Parenteral Screening Instruments Sales Forecast by Type (2022-2027)
6.4.2 United States Non-invasive Parenteral Screening Instruments Revenue Forecast by Type (2022-2027)
6.4.3 United States Non-invasive Parenteral Screening Instruments Price Forecast by Type (2022-2027)
6.5 United States Non-invasive Parenteral Screening Instruments Historic Market Review by Application (2016-2021)
6.5.1 United States Non-invasive Parenteral Screening Instruments Sales Market Share by Application (2016-2021)
6.5.2 United States Non-invasive Parenteral Screening Instruments Revenue Market Share by Application (2016-2021)
6.5.3 United States Non-invasive Parenteral Screening Instruments Price by Application (2016-2021)
6.6 United States Non-invasive Parenteral Screening Instruments Market Estimates and Forecasts by Application (2022-2027)
6.6.1 United States Non-invasive Parenteral Screening Instruments Sales Forecast by Application (2022-2027)
6.6.2 United States Non-invasive Parenteral Screening Instruments Revenue Forecast by Application (2022-2027)
6.6.3 United States Non-invasive Parenteral Screening Instruments Price Forecast by Application (2022-2027)

7 North America
7.1 North America Non-invasive Parenteral Screening Instruments Market Size YoY Growth 2016-2027
7.2 North America Non-invasive Parenteral Screening Instruments Market Facts & Figures by Country
7.2.1 North America Non-invasive Parenteral Screening Instruments Sales by Country (2016-2021)
7.2.2 North America Non-invasive Parenteral Screening Instruments Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Non-invasive Parenteral Screening Instruments Market Size YoY Growth 2016-2027
8.2 Asia Pacific Non-invasive Parenteral Screening Instruments Market Facts & Figures by Region
8.2.1 Asia Pacific Non-invasive Parenteral Screening Instruments Sales by Region (2016-2021)
8.2.2 Asia Pacific Non-invasive Parenteral Screening Instruments Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam

9 Europe
9.1 Europe Non-invasive Parenteral Screening Instruments Market Size YoY Growth 2016-2027
9.2 Europe Non-invasive Parenteral Screening Instruments Market Facts & Figures by Country
9.2.1 Europe Non-invasive Parenteral Screening Instruments Sales by Country (2016-2021)
9.2.2 Europe Non-invasive Parenteral Screening Instruments Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Non-invasive Parenteral Screening Instruments Market Size YoY Growth 2016-2027
10.2 Latin America Non-invasive Parenteral Screening Instruments Market Facts & Figures by Country
10.2.1 Latin America Non-invasive Parenteral Screening Instruments Sales by Country (2016-2021)
10.2.2 Latin America Non-invasive Parenteral Screening Instruments Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Non-invasive Parenteral Screening Instruments Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Non-invasive Parenteral Screening Instruments Market Facts & Figures by Country
11.2.1 Middle East and Africa Non-invasive Parenteral Screening Instruments Sales by Country (2016-2021)
11.2.2 Middle East and Africa Non-invasive Parenteral Screening Instruments Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 GE Healthcare
12.1.1 GE Healthcare Corporation Information
12.1.2 GE Healthcare Description and Business Overview
12.1.3 GE Healthcare Non-invasive Parenteral Screening Instruments Sales, Revenue and Gross Margin (2016-2021)
12.1.4 GE Healthcare Non-invasive Parenteral Screening Instruments Products Offered
12.1.5 GE Healthcare Recent Development
12.2 Philips
12.2.1 Philips Corporation Information
12.2.2 Philips Description and Business Overview
12.2.3 Philips Non-invasive Parenteral Screening Instruments Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Philips Non-invasive Parenteral Screening Instruments Products Offered
12.2.5 Philips Recent Development
12.3 Illumina
12.3.1 Illumina Corporation Information
12.3.2 Illumina Description and Business Overview
12.3.3 Illumina Non-invasive Parenteral Screening Instruments Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Illumina Non-invasive Parenteral Screening Instruments Products Offered
12.3.5 Illumina Recent Development
12.4 Thermo Fisher Scientific
12.4.1 Thermo Fisher Scientific Corporation Information
12.4.2 Thermo Fisher Scientific Description and Business Overview
12.4.3 Thermo Fisher Scientific Non-invasive Parenteral Screening Instruments Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Thermo Fisher Scientific Non-invasive Parenteral Screening Instruments Products Offered
12.4.5 Thermo Fisher Scientific Recent Development
12.5 Roche
12.5.1 Roche Corporation Information
12.5.2 Roche Description and Business Overview
12.5.3 Roche Non-invasive Parenteral Screening Instruments Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Roche Non-invasive Parenteral Screening Instruments Products Offered
12.5.5 Roche Recent Development
12.6 PacBio
12.6.1 PacBio Corporation Information
12.6.2 PacBio Description and Business Overview
12.6.3 PacBio Non-invasive Parenteral Screening Instruments Sales, Revenue and Gross Margin (2016-2021)
12.6.4 PacBio Non-invasive Parenteral Screening Instruments Products Offered
12.6.5 PacBio Recent Development
12.7 Perkinelmer
12.7.1 Perkinelmer Corporation Information
12.7.2 Perkinelmer Description and Business Overview
12.7.3 Perkinelmer Non-invasive Parenteral Screening Instruments Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Perkinelmer Non-invasive Parenteral Screening Instruments Products Offered
12.7.5 Perkinelmer Recent Development
12.8 Qiagen
12.8.1 Qiagen Corporation Information
12.8.2 Qiagen Description and Business Overview
12.8.3 Qiagen Non-invasive Parenteral Screening Instruments Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Qiagen Non-invasive Parenteral Screening Instruments Products Offered
12.8.5 Qiagen Recent Development
12.9 Agilent Technologies
12.9.1 Agilent Technologies Corporation Information
12.9.2 Agilent Technologies Description and Business Overview
12.9.3 Agilent Technologies Non-invasive Parenteral Screening Instruments Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Agilent Technologies Non-invasive Parenteral Screening Instruments Products Offered
12.9.5 Agilent Technologies Recent Development
12.10 BGI Group
12.10.1 BGI Group Corporation Information
12.10.2 BGI Group Description and Business Overview
12.10.3 BGI Group Non-invasive Parenteral Screening Instruments Sales, Revenue and Gross Margin (2016-2021)
12.10.4 BGI Group Non-invasive Parenteral Screening Instruments Products Offered
12.10.5 BGI Group Recent Development
12.11 GE Healthcare
12.11.1 GE Healthcare Corporation Information
12.11.2 GE Healthcare Description and Business Overview
12.11.3 GE Healthcare Non-invasive Parenteral Screening Instruments Sales, Revenue and Gross Margin (2016-2021)
12.11.4 GE Healthcare Non-invasive Parenteral Screening Instruments Products Offered
12.11.5 GE Healthcare Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Non-invasive Parenteral Screening Instruments Industry Trends
13.2 Non-invasive Parenteral Screening Instruments Market Drivers
13.3 Non-invasive Parenteral Screening Instruments Market Challenges
13.4 Non-invasive Parenteral Screening Instruments Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Non-invasive Parenteral Screening Instruments Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer